Vasopharm drug could limit damage caused by brain injuriesGerman biotech moves into phase 3 after a long wait Share XVasopharm drug could limit damage caused by brain injurieshttps://pharmaphorum.com/news/vasopharm-begins-phase-3-trial-brain-injury-drug/